(American Friends of Tel Aviv University) In a new study published in Nature Neuroscience, Dr. Inna Slutsky of Tel Aviv University’s Sackler Faculty of Medicine finds that the amyloid-beta protein, currently the target of Alzheimer’s drug research, is essential for normal information transfer through nerve cell networks in the brain. “If this protein is removed from the brain,” says Dr. Slutsky, “it may cause an impairment of neuronal function, as well as a further and faster accumulation of amyloid-beta in Alzheimer’s.”
Read the full story here...
EurekAlert offers several feeds for breaking science news headlines. As part of the Reactive Reports chemistry news aggregation service, otherwise known as Reactor, we offer the chemistry, materials, nano and related feed here for RR readers. You can find out more about Eurekalert here.
If you're lucky, the following quote may be relevant in some way to the post above, but then again...

Popular Posts